David F.  Melcher net worth and biography

David Melcher Biography and Net Worth

Director of Embecta

Lieutenant General (Ret) David F. Melcher serves as the Chairman of embecta, and was an Independent Director at Becton, Dickinson & Company (BD) from 2018-22, and at CR Bard Corporation (Bard) from 2014-2017. He also currently serves as an Independent Director at the United Services Automobile Association (USAA) and is on the Board of Managers for GM Defense, LLC, a wholly owned subsidiary of GM Corporation. He was also a former Lead Director of Cubic Corporation, a defense and transportation company that was bought by Veritas Capital in 2021.

In December 2017, LTG Melcher retired as President and Chief Executive Officer of Aerospace Industries Association, a trade association representing major aerospace and defense manufacturers and suppliers, a position he had held since 2015. From 2011 to 2015, he served as Chief Executive Officer, President and a director of Exelis Inc. (Exelis), a global aerospace defense, information and technology services company. Exelis, which was bought by Harris Corporation in 2015, was formerly a division of ITT Corporation that LTG Melcher led for three years before being spun off as a public company in 2011.

A graduate of both West Point and Harvard Business School, LTG Melcher provided over 32 years of distinguished service in the U.S. Army, having commanded in both light and heavy divisions, as Commander of the US Army Corps of Engineers Southwestern Division, and as the Army’s Deputy Chief of Staff for Programs.

What is David F. Melcher's net worth?

The estimated net worth of David F. Melcher is at least $1.01 million as of May 23rd, 2025. Mr. Melcher owns 86,681 shares of Embecta stock worth more than $1,012,434 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Melcher may own. Learn More about David F. Melcher's net worth.

How do I contact David F. Melcher?

The corporate mailing address for Mr. Melcher and other Embecta executives is , , . Embecta can also be reached via phone at 201-847-6880 and via email at [email protected]. Learn More on David F. Melcher's contact information.

Has David F. Melcher been buying or selling shares of Embecta?

David F. Melcher has not been actively trading shares of Embecta during the last ninety days. Most recently, on Friday, May 23rd, David F. Melcher bought 10,000 shares of Embecta stock. The stock was acquired at an average cost of $10.60 per share, with a total value of $106,000.00. Following the completion of the transaction, the director now directly owns 86,681 shares of the company's stock, valued at $918,818.60. Learn More on David F. Melcher's trading history.

Who are Embecta's active insiders?

Embecta's insider roster includes Jacob Elguicze (SVP, Chief Financial Officer), Devdatt Kurdikar (CEO), Jeffrey Mann (General Counsel and Head of Business Development), and David Melcher (Director). Learn More on Embecta's active insiders.

Are insiders buying or selling shares of Embecta?

During the last year, Embecta insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $106,000.00. During the last year, insiders at the sold shares 1 times. They sold a total of 3,100 shares worth more than $50,778.00. The most recent insider tranaction occured on May, 23rd when Director David F Melcher bought 10,000 shares worth more than $106,000.00. Insiders at Embecta own 0.4% of the company. Learn More about insider trades at Embecta.

Information on this page was last updated on 5/23/2025.

David F. Melcher Insider Trading History at Embecta

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/23/2025Buy10,000$10.60$106,000.0086,681View SEC Filing Icon  
2/12/2024Buy2,000$16.25$32,500.0045,080View SEC Filing Icon  
9/8/2023Buy6,233$15.77$98,294.4127,698View SEC Filing Icon  
2/15/2023Buy3,100$32.51$100,781.0021,465View SEC Filing Icon  
See Full Table

David F. Melcher Buying and Selling Activity at Embecta

This chart shows David F Melcher's buying and selling at Embecta by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Embecta Company Overview

Embecta logo
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Read More

Today's Range

Now: $11.68
Low: $11.50
High: $12.03

50 Day Range

MA: $13.73
Low: $11.68
High: $14.71

2 Week Range

Now: $11.68
Low: $9.20
High: $21.23

Volume

923,892 shs

Average Volume

545,451 shs

Market Capitalization

$683.40 million

P/E Ratio

7.17

Dividend Yield

5.02%

Beta

1.1